To require the United States Postal Service to sell the Alzheimer's semipostal stamp for 6 additional years.

Bill: 116-hr-3113
Sponsor: full_name: Rep. Waters, Maxine [D-CA-43]
Introduced: 2019-06-05
Policy area: Government Operations and Politics
Subjects: Aging

Health programs administration and funding

Medical research

Neurological disorders

Postal service

Research administration and funding
Latest action: action_date: 2019-06-06
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2019-06-05
action_desc: Introduced in House
text: <p>This bill directs the U.S. Postal Service (USPS) to continue to sell the Alzheimer's disease semipostal stamp for an additional six years. The USPS must continue to transfer proceeds from the sale of the stamp to the National Institutes of Health to fund medical research relating to Alzheimer's disease.</p>

tv_txt: I 116th CONGRESS 1st Session H. R. 3113 IN THE HOUSE OF REPRESENTATIVES June 5, 2019 Ms. Waters (for herself and Mr. Smith of New Jersey ) introduced the following bill; which was referred to the Committee on Oversight and Reform , and in addition to the Committee on Energy and Commerce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To require the United States Postal Service to sell the Alzheimer’s semipostal stamp for 6 additional years.

1. Alzheimer’s semipostal stamp (a) Definitions In this section— (1) the term Alzheimer’s semipostal stamp means the Alzheimer’s semipostal stamp that the Postal Service began offering for sale on November 30, 2017, under the discretionary authority under section 416(b) of title 39, United States Code; (2) the term Postal Service means the United States Postal Service; and (3) the term semipostal stamp has the meaning given the term semipostal in section 416(a)(1) of title 39, United States Code. (b) Continued sale In order to afford a convenient way for members of the public to contribute to funding for medical research relating to Alzheimer’s disease, the Postal Service shall continue to sell the Alzheimer’s semipostal stamp for a 6-year period beginning on the date on which the Postal Service, but for the enactment of this Act, would have discontinued sales of the Alzheimer’s semipostal stamp. (c) Terms and conditions (1) In general Except as provided in this subsection, the sale of the Alzheimer’s semipostal stamp during the period described in subsection (b) shall be governed by section 416 of title 39, United States Code, and regulations issued under that section. (2) Disposition of proceeds All amounts becoming available from the sale of the Alzheimer’s semipostal stamp (as determined under section 416(d) of title 39, United States Code) during the period described in subsection (b) of this section shall be transferred to the National Institutes of Health, for the purpose described in that subsection, through payments which shall be made not less frequently than 2 times a year. (3) Legal authority and effect During the period described in subsection (b), the Alzheimer’s semipostal stamp shall be considered to be issued under this section and not under subsection (b) of section 416 of title 39, United States Code, including for purposes of any limitation under that section (including any regulation prescribed under subsection (e)(1)(C) of that section) relating to whether more than 1 semipostal stamp may be offered for sale at the same time.